It has been reported that ginsenoside Rh 2 , a purified ginseng saponin with a dammarane skeleton, has anticarcinogenic effects on mammalian cells. To determine the significance of these effects on multistage carcinogenesis, we utilized the BALB/c 3T3 cell system. In an in vitro two-stage neoplastic transformation assay, the initiating activity of 3-methylcholanthrene (3-MCA) was suppressed by Rh 2 (≥ ≥ ≥ ≥1 × × × ×10 − − − −5 M) in both BALB/c 3T3 A31-1-1 cells and the more carcinogen-susceptible variant A31-1-13 cells. The suppressive effects in this concentration range were thought to be caused by suppression of DNA replication via indirect Cdk2 inhibition. On the other hand, the promotion steps of both the target cells were not affected by Rh 2 even if the transformation frequency was enhanced by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). To examine the other effects of Rh 2 on carcinogenesis, we turned our attention to the metastatic phenotype. Using metastatic src-transformed A31-1-1 cells, we found that Rh 2 augmented the metastatic potential in an experimental metastasis assay. These data indicate that Rh 2 has diverse effects on the expression of the transformed phenotype in BALB/c 3T3 cells, but support the idea that growth suppression is likely to be a major mechanism of the anticarcinogenic effects of Rh 2 .
The discovery of new cancer-preventing agents and elucidation of the basic mechanisms relevant to cancer prevention provide various opportunities for us to design new drugs or to discover micronutrients for suppressing carcinogenesis and/or cancer invasion and metastasis. There are a number of natural and artificial sources for chemical compounds effective in preventing cancer, and many effective agents are being discovered and characterized. 1) The ingredients of medicines used in folk remedies are one such source in the search for chemopreventive agents. Ginsenoside Rh 2 has been purified from the root of Panax ginseng C. A. Meyer, an important medicinal resource for thousands of years in China, Korea, and Japan, and has been reported to have anticancer potential based on growth inhibition activity, [2] [3] [4] the induction of untransformed phenotype, [5] [6] [7] [8] [9] [10] the induction of apoptosis, [11] [12] [13] [14] [15] [16] and the modulation of DNA metabolism. [17] [18] [19] In this paper, using a twostage transformation system with BALB/c 3T3 cells, 20) we investigated the possibility of utilizing Rh 2 for cancer chemoprevention. Our results indicate that Rh2 has a chemopreventing activity in the initiation step of in vitro carcinogenesis, but does not have any effect on the tumor promotion step. In addition, it caused an enhancement of the metastatic potential of src-transformed BALB/c 3T3 cells.
MATERIALS AND METHODS

Cell cultures
The BALB/c 3T3 A31 variant cell lines 1-1 (A31-1-1) and 1-13 (A31-1-13) were originally established by Kakunaga and Crow 21) and have different susceptibilities to radiation-and chemical-induced neoplastic transformation. 20) The different susceptibilities were thought to be due to their different potentials for expression of transformed phenotype during the promotion step of carcinogenesis. [22] [23] [24] For in vitro transformation assay, we used cells at an early passage number from the original cell stock. Highly metastatic v-src-transformed A31-1-1 cells (1-1src) and poorly metastatic c-Ha-ras-transformed A31-1-1 cells (1-1ras1000) were also used in this study. 25, 26) All the cells were cultured in Eagle's minimal essential medium supplemented with 10% fetal bovine serum (Lot No. SF70521, Bocknek Laboratories, Etobicoke, Ontario, Canada) in 5% CO 2 at 37°C. The transformation experiments were also performed with the same lot of serum. In vitro transformation assay Exponentially growing cells (10 4 ) were seeded onto 60-mm culture dishes (Nalge Nunc International, Tokyo), with 4 ml of culture medium in the presence of 10% fetal bovine serum. Transformation was initiated 24 h later with 2.5 µg/ml 3-methylcholanthrene (3-MCA) for A31-1-1 cells or with 1 µg/ml 3-MCA for A31-1-13 cells. After the initiation period with 3-MCA for 24 h, the cells were treated according to the 3 To whom correspondence should be addressed.
E-mail: haruo@hiroshima-u.ac.jp following protocols. To test the effect of Rh 2 on the initiation step of cell transformation, the initiated cells were treated with Rh 2 in the presence of 2% fetal bovine serum. Two days later, the Rh 2 -containing medium was replaced with fresh medium containing 10% fetal bovine serum and then culture was continued by replacing the fresh medium twice weekly. To test the effect of Rh 2 on the promotion step of cell transformation, the initiated cells were cultured in fresh medium containing 10% fetal bovine serum by replacing the fresh medium once. Seven days later, the culture medium was replaced by fresh medium containing phorbol ester and/or Rh 2 . Promotion was continued by replacing the medium containing these factors twice weekly. Two weeks later, the culture medium was replaced by fresh medium containing 10% fetal bovine serum and then culture was continued by replacing the fresh medium twice weekly. Thirty to 35 days after the initiation of the experiment, all cultures were fixed in methanol and stained with 2% Giemsa solution. Morphological transformation was determined under a dissecting microscope. Only densely stained multilayer foci with criss-crossing of the cells at their periphery were scored.
20)
Assay of Cdk2 activity The immune complex kinase assay was carried out as described by Matsushime et al.
27)
The 3-MCA-initiated cells treated with Rh 2 to test the effect of Rh 2 on the initiation step of cell transformation were collected, suspended in immunoprecipitation buffer and sonicated. Lysates (200 mg protein) were precipitated with protein A-Sepharose beads precoated with anti-Cdk2 antibody (Santa Cruz BioTechnology, Santa Cruz, CA). The immunoprecipitated proteins on the beads were washed and suspended in kinase buffer containing the substrate, histone H1 (1 mg, Roche Diagnostics, Tokyo), cold adenosine 5′-triphosphate (ATP) (50 mM) and [γ-32 P]ATP (5 mCi, Amersham Pharmacia Biotech, Tokyo, ~3000 Ci/ mmol). To determine the in vitro suppression effect, Rh 2 (2×10 −5 M) or olomoucine (2×10 − 5 M, Promega, Madison, WI) was added to the reaction mixture. Olomoucine is a chemically synthesized Cdk2 inhibitor that is competitive for ATP binding. 28) After incubation for the kination, the samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The phosphorylated protein was autoradiographically visualized and the incorporated 32 P was measured with a Bio-Imaging Analyzer (BAS 2000, Fuji, Tokyo). Experimental metastasis assay Male BALB/c nude mice were obtained at 6-7 weeks of age. Exponentially growing 1-1src cells or 1-1ras1000 cells were treated with or without Rh 2 (2×10 −5 M for 24 h). The cells were collected by trypsinization and washed with phosphate-buffered saline. For the experimental metastasis assay, 5×10 5 cells were injected intravenously into the tail vein of 7-to 8-week-old nude mice. The mice injected with the cells were killed after 2 weeks and autopsied to establish the extent of metastasis. 25) Metastatic lung nodules were counted after insufflation with 15% India ink.
29)
RESULTS
To establish whether Rh 2 has anticarcinogenic effects on cell transformation, we used a two-stage transformation system with BALB/c 3T3 cells. In this system, variant cell lines with different susceptibilities to chemical and physical carcinogens are available as target cells for the estimation of initiation and promotion effects of agents. 20) Using this system, therefore, it is possible to evaluate the chemoprevention effects of Rh 2 on the two distinct stages of carcinogenesis, 'initiation' and 'promotion,' in cells with different levels of carcinogen susceptibility. 20, 21, 30, 31) It was reported previously that Rh 2 had a suppressive activity on both spontaneous and carcinogen-induced formation of sister chromatid exchanges at Rh 2 concentrations lower than 1×10 −10 M. 19) To assess this chemoprevention activity, we first applied Rh 2 during the initiation period (48 h; 2nd-3rd day of BALB/c 3T3 cell transformation protocol) at a wide range of concentrations (2×10 −5 -1×10 −12 M) to 3-MCA-initiated cells (transformation-susceptible A31-1-1 cells treated with 2.5 µg/ml 3-MCA for 24 h and highly transformation-susceptible A31-1-13 cells treated with 1 µg/ml 3-MCA for 24 h). In control culture without 3-MCA treatment, Rh 2 showed no effect on BALB/c 3T3 cell transformation at any concentration tested (data not shown). This is consistent with the report that Rh 2 is not mutagenic in the Ames test 32) using Salmonella typhimurium (unpublished data). In initiated cells, the transformation frequencies of both A31-1-1 and A31-1-13 cells were significantly suppressed by Rh 2 only at a high concentration range (≥1×10 −5 M), while no effect was found at a lower concentration range (1×10 −7 -1×10 − 12 M) (Fig. 1) . The inhibition of DNA replication after carcinogen treatment reduces the frequency of transformation.
33, 34) Rh 2 induces G 1 block at the high concentration range via indirect Cdk2-inhibition (≥1×10
2) Thus, the suppressive effects of Rh 2 on the initiation of transformation are thought to be due to this mechanism. Indeed, the dose-response of Cdk2 inhibition by Rh 2 treatment was correlated closely with the Rh 2 -induced suppression of cell transformation when measured by the immune complex kinase assay described previously, 2) although Rh 2 did not directly inhibit the Cdk2 activity in vitro (Fig. 2) .
To test the chemopreventive effects of Rh 2 on the promotion step of cell transformation, we next applied Rh 2 during the promotion period (2 weeks; 8th-22nd day of BALB/c 3T3 cell transformation protocol) to 3-MCA-initiated A31-1-1 and A31-1-13 cells (A31-1-1 cells treated with 2.5 µg/ml 3-MCA for 24 h and A31-1-13 cells treated with 1 µg/ml 3-MCA for 24 h) and also to 3-MCA-initiated 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted A-31-1-1 cells (10 −1 µg/ml TPA for 2 weeks during 8th-22nd day). The data clearly indicated that Rh 2 had no effect at any concentration range (2×10 −5 -1×10 −12 M) on the tumor promotion step in the BALB/c 3T3 cell transformation system (Fig. 3) .
Rh 2 is known to have some biological effects on cell differentiation, such as the stimulation of melanogenesis in melanoma cells, 7) glucocorticoid-like action in teratocarcinoma cells, 9) and the modulation of protein kinase C activity in HL-60 cells. 10) Thus, Rh 2 may modulate certain cancerous features in transformed cells. To examine this possibility in the BALB/c 3T3 cell system, we turned our attention to the effects on the metastatic phenotype in srctransformed A31-1-1 cells (1-1src cells). 1-1src is metastatic to the lung, and the metastatic potential can be quantitatively detected by intravenous injection of the cells into BALB/c nude mice. 25 ) When 1-1src cells were treated with Rh 2 (2×10 − 5 M for 48 h), the cells were growth-suppressed and their Cdk2 activity was reduced. This Cdk2 reduction induced by Rh 2 was similar to that observed in Rh 2 -treated A31-1-1 and A31-1-13 cells. When the Rh 2 -treated 1-1src cells were intravenously injected into the mice, we found that the metastatic potential of the treated cells was significantly increased (Fig. 4A) . Quantification was performed by counting pulmonary metastasis nodules, and the data are presented in Fig. 4B . A similar enhancement effect on metastatic potential was observed when ras-transformed A31-1-1 cells (1-1ras1000 cells) were treated with Rh 2 (2×10 −5 M for 48 h) (Fig. 4B) . Such an enhancement effect was not observed at a lower Rh 2 concentration range (≤1×10 −7 M) (data not shown).
DISCUSSION
Here, we have shown that Rh 2 has an anticarcinogenic effect on the BALB/c 3T3 cell transformation system during the initiation step and also has an enhancing effect on the metastatic potential of src-transformed BALB/c 3T3 cells. The transformation frequency is known to be reduced by suppression of DNA replication and to be enhanced by stimulation of DNA replication after carcinogen treatment.
33, 34) Rh 2 is likely to affect the transforma- Fig. 1 were collected, suspended in immunoprecipitation buffer and sonicated. Lysates were immunoprecipitated with anti-Cdk2 antibody and suspended in kinase buffer. To determine an in vitro effect on the suppression of Cdk2, Rh 2 (2×10 −5 M) or olomoucine (2×10 −5 M, positive control for Cdk2 suppression) was added to the immunoprecipitated samples from control A31-1-13 cells. After incubation for kination, the samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and phosphorylated proteins were autoradiographically visualized. The incorporated 32 P was measured by a Bio-Imaging Analyzer. Columns, means of data from two independent experiments. tion frequency by this mechanism through Cdk2 inhibition in the higher concentration range (≥1×10 −5 M), but to have no effect on the tumor promotion step after the fixation of the transformation initiation. Zhu et al. 19) reported that the formation of sister chromatid exchanges in human lymphocytes was suppressed by Rh 2 treatment even at an ultra low concentration of Rh 2 (1×10 −13 M). However, in this study, no significant effect on BALB/c 3T3 cell transformation was detected at such a low concentration of Rh 2 .
On the other hand, during the late stages of carcinogenesis in the BALB/c 3T3 cell system, Rh 2 has an enhancing effect on the metastatic potential of src-transformed 1-1src cells at the same concentration range as that which is effective for the inhibition of Cdk2. In this concentration range, the Src kinase activity of the cells was not altered by Rh 2 treatment (data not shown). One possible explanation of the enhancing effect on metastatic potential is that Rh 2 -induced Cdk2 inhibition contributes to the prevention of apoptosis of the intravenously injected cells in the blood and lung. Indeed, Rh 2 -treated 1-1src cells are resistant to X-ray-induced apoptosis (unpublished data). Moreover, the forced overexpression of a dominant negative form of Cdk2 was found to have a suppressive effect on apoptosis in doxorubicin-treated colorectal tumor cells. 35) Thus, Cdk2 inhibition is likely to produce an apoptosisresistant state resulting in an enhanced metastatic potential in transformed cells. Another possible explanation is that the modulation of cellular surfaces by Rh 2 , such as increment of the binding sites for peanut agglutinin, 36) results in the enhancement of metastatic potential caused by adhesion to blood vessel endothelial cells or between the Rh 2 -treated cells. Although further studies are required to elucidate the molecular mechanism of Rh 2 action on the metastatic potential in tumor cells, such an action suggests that possible chemopreventive and chemotherapeuetic agents should be carefully evaluated for their effectiveness and side effects. To our knowledge, this paper is the first report to convincingly show side effects on a transformed phenotype by a component of ginseng. As not only shown by us in this report, but also pointed out in a review article, 37) the diverse effects of natural components should be understood carefully and accurately in order to discover, develop, and apply them to cancer therapy and for health promotion. 8, 2001) 
